Optimal Immunotherapy (Anti-PD-1 or anti-PD-L1) + CT for Advanced Squamous NSCLC: anti-PD-1 antibody therapy + CT may have superior efficacy compared to anti-PD-L1 antibody combination for patients with PD-L1 low/negative advanced squamous NSCLC. https://t
627 followers
243 followers
RT @sitcancer: #JITC Commentary: Which is the optimal immunotherapy for advanced squamous non-small-cell lung cancer in combination with ch…
41 followers
RT @sitcancer: #JITC Commentary: Which is the optimal immunotherapy for advanced squamous non-small-cell lung cancer in combination with ch…
2,015 followers
RT @sitcancer: #JITC Commentary: Which is the optimal immunotherapy for advanced squamous non-small-cell lung cancer in combination with ch…